Antiviral Activity of Hatay Propolis Against Replication of Herpes Simplex Virus Type 1 and Type 2. 2016

Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
Department of Histology and Embryology, Mustafa Kemal University, Medical Faculty, Hatay, Turkey.

BACKGROUND Propolis is a bee product widely used in folk medicine and possessing many pharmacological properties. In this study we aimed to investigate: i) the antiviral activities of Hatay propolis samples against HSV-1 and HSV-2 in HEp-2 cell line, and ii) the presence of the synergistic effects of propolis with acyclovir against these viruses. MATERIAL AND METHODS All experiments were carried out in HEp-2 cell cultures. Proliferation assays were performed in 24-well flat bottom microplates. We inoculated 1x105 cells per ml and RPMI 1640 medium with 10% fetal calf serum into each well. Studies to determine cytotoxic effect were performed. To investigate the presence of antiviral activity of propolis samples, different concentrations of propolis (3200, 1600, 800, 400, 200, 100, 75, 50, and 25 μg/mL) were added into the culture medium. The amplifications of HSV-1 and HSV-2 DNA were performed by real-time PCR method. Acyclovir (Sigma, USA) was chosen as a positive control. Cell morphology was evaluated by scanning electron microscopy (SEM). RESULTS The replication of HSV-1 and HSV-2 was significantly suppressed in the presence of 25, 50, and 100 μg/mL of Hatay propolis. We found that propolis began to inhibit HSV-1 replication after 24 h of incubation and propolis activity against HSV-2 was found to start at 48 h following incubation. The activity of propolis against both HSV-1 and HSV-2 was confirmed by a significant decrease in the number of viral copies. CONCLUSIONS We determined that Hatay propolis samples have important antiviral effects compared with acyclovir. In particular, the synergy produced by antiviral activity of propolis and acyclovir combined had a stronger effect against HSV-1 and HSV-2 than acyclovir alone.

UI MeSH Term Description Entries
D008519 Medicine, Traditional Systems of medicine based on cultural beliefs and practices handed down from generation to generation. The concept includes mystical and magical rituals (SPIRITUAL THERAPIES); PHYTOTHERAPY; and other treatments which may not be explained by modern medicine. Ethnomedicine,Folk Medicine,Folk Remedies,Home Remedies,Medicine, Folk,Medicine, Indigenous,Medicine, Primitive,Indigenous Medicine,Primitive Medicine,Traditional Medicine,Folk Remedy,Home Remedy,Remedies, Folk,Remedies, Home,Remedy, Folk,Remedy, Home
D011429 Propolis A resinous substance obtained from beehives that is used traditionally as an antimicrobial. It is a heterogeneous mixture of many substances. Bee Bread,Bee Glue,Bread, Bee,Glue, Bee
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D018258 Herpesvirus 2, Human A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact. HSV-2,Herpes Simplex Virus 2,Human Herpesvirus 2,HHV-2,Herpes Simplex Virus Type 2,Herpesvirus 2 (alpha), Human
D018259 Herpesvirus 1, Human The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions. HSV-1,Herpes Simplex Virus 1,HHV-1,Herpes Simplex Virus Type 1,Herpesvirus 1 (alpha), Human,Human Herpesvirus 1

Related Publications

Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
January 2022, Drug design, development and therapy,
Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
June 2015, Antiviral research,
Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
December 2002, Antiviral research,
Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
February 2002, Journal of medical virology,
Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
September 1993, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
March 1992, Bioscience, biotechnology, and biochemistry,
Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
April 2009, International journal of molecular medicine,
Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
September 2001, Phytotherapy research : PTR,
Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
January 2008, Natural product research,
Ayse Yildirim, and Gulay Gulbol Duran, and Nizami Duran, and Kemal Jenedi, and Behiye Sezgin Bolgul, and Meral Miraloglu, and Mustafa Muz
September 2012, Archives of pharmacal research,
Copied contents to your clipboard!